Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001731122-23-000152
Filing Date
2023-02-07
Accepted
2023-02-07 17:11:05
Documents
47
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q e4385_10-q.htm   iXBRL 10-Q 500346
2 EXHIBIT 4.1 e4385_ex4-1.htm EX-4.1 81402
3 EXHIBIT 10.1 e4385_ex10-1.htm EX-10.1 303069
4 EXHIBIT 31.1 e4385_ex31-1.htm EX-31.1 8130
5 EXHIBIT 31.2 e4385_ex31-2.htm EX-31.2 7934
6 EXHIBIT 32.1 e4385_ex32-1.htm EX-32.1 6009
7 GRAPHIC image_001.jpg GRAPHIC 42671
8 GRAPHIC image_002.jpg GRAPHIC 28367
  Complete submission text file 0001731122-23-000152.txt   3221839

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE avxl-20221231.xsd EX-101.SCH 22778
10 XBRL CALCULATION FILE avxl-20221231_cal.xml EX-101.CAL 28491
11 XBRL DEFINITION FILE avxl-20221231_def.xml EX-101.DEF 74521
12 XBRL LABEL FILE avxl-20221231_lab.xml EX-101.LAB 189852
13 XBRL PRESENTATION FILE avxl-20221231_pre.xml EX-101.PRE 146593
41 EXTRACTED XBRL INSTANCE DOCUMENT e4385_10-q_htm.xml XML 329334
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37606 | Film No.: 23596033
SIC: 2836 Biological Products, (No Diagnostic Substances)